S Lamusuo1,2,3, J Hirvonen3, P Lindholm1,4, I K Martikainen5, N Hagelberg6, R Parkkola3,7, T Taiminen8, J Hietala3,8, S Helin3, A Virtanen4, A Pertovaara9, S K Jääskeläinen4. 1. Department of Neurology, Turku University Hospital, Finland. 2. Division of Clinical Neuroscience, University of Turku, Finland. 3. Turku PET Centre, University of Turku, Finland. 4. Department of Clinical Neurophysiology, Turku University Hospital and University of Turku, Finland. 5. Department of Physiology, Turku University Hospital and University of Turku, Finland. 6. Pain Clinic, Turku University Hospital and University of Turku, Finland. 7. Department of Radiology, Turku University Hospital and University of Turku, Finland. 8. Department of Psychiatry, Turku University Hospital and University of Turku, Finland. 9. Department of Physiology, Faculty of Medicine, University of Helsinki, Finland.
Abstract
BACKGROUND:Repetitive transcranial magnetic stimulation (rTMS) at M1/S1 cortex has been shown to alleviate neuropathic pain. OBJECTIVES: To investigate the possible neurobiological correlates of cortical neurostimulation for the pain relief. METHODS: We studied the effects of M1/S1 rTMS on nociception, brain dopamine D2 and μ-opioid receptors using a randomized, sham-controlled, double-blinded crossover study design and 3D-positron emission tomography (PET). Ten healthy subjects underwentactive and sham rTMS treatments to the right M1/S1 cortex with E-field navigated device. Dopamine D2 and μ-receptor availabilities were assessed with PET radiotracers [11 C]raclopride and [11 C]carfentanil after each rTMS treatment. Thermal quantitative sensory testing (QST), contact heat evoked potential (CHEP) and blink reflex (BR) recordings were performed between the PET scans. RESULTS: μ-Opioid receptor availability was lower after active than sham rTMS (P ≤ 0.0001) suggested release of endogenous opioids in the right ventral striatum, medial orbitofrontal, prefrontal and anterior cingulate cortices, and left insula, superior temporal gyrus, dorsolateral prefrontal cortex and precentral gyrus. There were no differences in striatal dopamine D2 receptor availability between active and sham rTMS, consistent with lack of long-lasting measurable dopamine release. Active rTMS potentiated the dopamine-regulated habituation of the BR compared to sham (P = 0.02). Thermal QST and CHEP remained unchanged after active rTMS. CONCLUSIONS:rTMS given to M1/S1 activates the endogenous opioid system in a wide brain network associated with processing of pain and other salient stimuli. Direct enhancement of top-down opioid-mediated inhibition may partly explain the clinical analgesic effects of rTMS. SIGNIFICANCE: Neurobiological correlates of rTMS for the pain relief are unclear. rTMS on M1/S1 with 11 C-carfentanyl-PET activates endogenous opioids. Thermal and heat pain thresholds remain unchanged. rTMS induces top-down opioid-mediated inhibition but not change the sensory discrimination of painful stimuli.
RCT Entities:
BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) at M1/S1 cortex has been shown to alleviate neuropathic pain. OBJECTIVES: To investigate the possible neurobiological correlates of cortical neurostimulation for the pain relief. METHODS: We studied the effects of M1/S1 rTMS on nociception, brain dopamine D2 and μ-opioid receptors using a randomized, sham-controlled, double-blinded crossover study design and 3D-positron emission tomography (PET). Ten healthy subjects underwent active and sham rTMS treatments to the right M1/S1 cortex with E-field navigated device. Dopamine D2 and μ-receptor availabilities were assessed with PET radiotracers [11 C]raclopride and [11 C]carfentanil after each rTMS treatment. Thermal quantitative sensory testing (QST), contact heat evoked potential (CHEP) and blink reflex (BR) recordings were performed between the PET scans. RESULTS: μ-Opioid receptor availability was lower after active than sham rTMS (P ≤ 0.0001) suggested release of endogenous opioids in the right ventral striatum, medial orbitofrontal, prefrontal and anterior cingulate cortices, and left insula, superior temporal gyrus, dorsolateral prefrontal cortex and precentral gyrus. There were no differences in striatal dopamine D2 receptor availability between active and sham rTMS, consistent with lack of long-lasting measurable dopamine release. Active rTMS potentiated the dopamine-regulated habituation of the BR compared to sham (P = 0.02). Thermal QST and CHEP remained unchanged after active rTMS. CONCLUSIONS: rTMS given to M1/S1 activates the endogenous opioid system in a wide brain network associated with processing of pain and other salient stimuli. Direct enhancement of top-down opioid-mediated inhibition may partly explain the clinical analgesic effects of rTMS. SIGNIFICANCE: Neurobiological correlates of rTMS for the pain relief are unclear. rTMS on M1/S1 with 11 C-carfentanyl-PET activates endogenous opioids. Thermal and heat pain thresholds remain unchanged. rTMS induces top-down opioid-mediated inhibition but not change the sensory discrimination of painful stimuli.
Authors: Philipp Riedel; Matthias Heil; Stephan Bender; Gabriel Dippel; Franziska M Korb; Michael N Smolka; Michael Marxen Journal: Hum Brain Mapp Date: 2019-07-03 Impact factor: 5.038
Authors: Blake A Kimmey; Nora M McCall; Lisa M Wooldridge; Theodore D Satterthwaite; Gregory Corder Journal: J Neurosci Res Date: 2020-12-13 Impact factor: 4.164
Authors: Stefano Giannoni-Luza; Kevin Pacheco-Barrios; Alejandra Cardenas-Rojas; Piero F Mejia-Pando; Maria A Luna-Cuadros; Judah L Barouh; Marina Gnoatto-Medeiros; Ludmilla Candido-Santos; Alice Barra; Wolnei Caumo; Felipe Fregni Journal: Pain Date: 2020-09-01 Impact factor: 7.926
Authors: Ruben Volkers; Esmay Giesen; Maudy van der Heiden; Mijke Kerperien; Sibylle Lange; Erkan Kurt; Robert van Dongen; Dennis Schutter; Kris C P Vissers; Dylan Henssen Journal: Neuromodulation Date: 2020-02-06
Authors: Jussi Nikkola; Anu Holm; Marjo Seppänen; Teemu Joutsi; Esa Rauhala; Antti Kaipia Journal: Int Neurourol J Date: 2020-06-30 Impact factor: 2.835
Authors: Marcos F DosSantos; Aleli T Oliveira; Natália R Ferreira; Antônio C P Carvalho; Paulo Henrique Rosado de Castro Journal: Pain Res Manag Date: 2018-11-13 Impact factor: 3.037